Performance Evaluation of a Custom Myeloid Assay on the Genexus Integrated Sequencer from a Wide Spectrum of Clinical Variants.
Open Access
- 10 July 2026
- journal article
- Published by Elsevier in The Journal of Molecular Diagnostics
- Vol. 28 (9) , 712-722
Abstract
No abstract availableKeywords
Funding Information
- Mayo Foundation for Medical Education and Research
- Life Technologies Corporation
This publication has 12 references indexed in Scilit:
- Molecular findings in myeloid neoplasmsInternational Journal of Laboratory Hematology, 2023
- The Times, They Are A-Changing: The Impact of Next-Generation Sequencing on Diagnosis, Classification, and Prognostication of Myeloid Malignancies With Focus on Myelodysplastic Syndrome, AML, and Germline PredispositionAmerican Society of Clinical Oncology Educational Book, 2023
- The KMT2A recombinome of acute leukemias in 2023Leukemia, 2023
- Navigating the contested borders between myelodysplastic syndrome and acute myeloid leukemiaFrontiers in Oncology, 2022
- International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic dataBlood, 2022
- The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic NeoplasmsLeukemia, 2022
- AML with inv(16)/t(16;16) and high-risk cytogenetic abnormalities: atypical features and unfavorable outcomeHematology, 2022
- Genetics of progression from MDS to secondary leukemiaBlood, 2020
- Acute promyelocytic leukemia with the translocation t(15;17)(q22;q21) associated with t(1;2)(q42~43;q11.2~12): a case reportJournal of Medical Case Reports, 2016
- The 2008 World Health Organization classification system for myeloproliferative neoplasmsCancer, 2009